PT-141 side effects in women can include nausea, flushing, and headache. Learn what research and user reports say, plus safety steps to discuss with a doctor.
PT-141 (bremelanotide) side effects in women are most often nausea, flushing, and headache. These reactions come from the drug's action on melanocortin receptors in the brain rather than from hormones, and they usually show up within an hour of an injection. Most are mild to moderate, but nausea is the single biggest reason women stop using it.
What PT-141 Is and Why Women Use It
PT-141 is the research name for bremelanotide, sold in the United States as Vyleesi. The FDA approved the 1.75 mg subcutaneous auto-injector in 2019 for premenopausal women with hypoactive sexual desire disorder (HSDD), a persistent lack of interest in sex that causes personal distress.
It is not a hormone and not an aphrodisiac in the casual sense. Bremelanotide activates melanocortin receptors, which are involved in pigmentation, appetite, and sexual desire pathways in the central nervous system. Dosing is on demand: one injection under the skin of the abdomen or thigh at least 45 minutes before anticipated sexual activity, no more than once in 24 hours and no more than eight times per month.
If you are reading up on pt-141 for women side effects, it helps to know that the published safety data come almost entirely from premenopausal women in company-sponsored trials, not from compounded or gray-market versions sold online.
The Most Common PT-141 Side Effects in Women
The percentages below come from the phase 3 trials that supported FDA approval at the labeled dose.
| Side effect | Roughly how often | What it feels like |
|---|---|---|
| Nausea | About 40% | Queasiness, usually within the first hour |
| Flushing | About 20% | Warmth or redness in the face, neck, or chest |
| Injection site reaction | About 13% | Stinging, redness, or a small lump |
| Headache | About 11% | Tension-type pain, sometimes with light sensitivity |
| Vomiting | About 5% | Usually follows a wave of nausea |
| Fatigue | About 4% | Sleepiness or low energy after dosing |
Nausea is the most frequently reported complaint and the most common reason women discontinue therapy. Clinical trial data on the side effects of pt 141 showed that roughly 40% of participants reported nausea, though most rated it mild and only a small share stopped treatment because of it.
Most of these effects are self-limiting and ease within a few hours. Eating a heavy, greasy meal beforehand does not reliably prevent nausea, and alcohol can worsen flushing and queasiness, so the label advises limiting alcohol around dosing.
Less Common but More Serious Concerns
Blood pressure changes
Bremelanotide can cause a temporary rise in blood pressure and a small drop in heart rate. The increase is usually brief and modest, but it matters for women with uncontrolled high blood pressure or known cardiovascular disease, because the drug is contraindicated in those groups.
Focal hyperpigmentation
Repeated use has been linked to darker patches of skin on the face, gums, and breasts. In the 24-week trials, focal hyperpigmentation appeared in roughly 1% of women, and in some cases the discoloration did not fully fade after the medication was stopped.
Effects on other oral medications
PT-141 can slow stomach emptying, which may change how quickly oral drugs are absorbed. If you take medication for diabetes, blood pressure, or birth control and you vomit soon after a dose, ask your prescriber whether your other medications are still working as expected.
PT-141 vs. Other Treatments for Low Sexual Desire
| Option | How it is taken | Common side effects | Approved for |
|---|---|---|---|
| PT-141 (bremelanotide) | Subcutaneous injection on demand | Nausea, flushing, headache, injection site reactions | Premenopausal women with HSDD |
| Flibanserin (Addyi) | Oral tablet, nightly | Dizziness, sleepiness, nausea, low blood pressure | Premenopausal women with HSDD |
| Testosterone (off-label) | Cream, gel, or injection | Acne, unwanted hair growth, voice changes | Not FDA-approved for women with HSDD |
| Sex therapy or couples counseling | Talk therapy sessions | No physical side effects | Any adult |
There is no single best option, and some clinicians combine approaches. A prescriber can help match the treatment to your health history, your blood pressure, and how often you want to dose.
Research Peptides Sold Online: A Different Risk Profile
Many people searching for pt 141 side effects women are actually looking at vials from research-chemical vendors, not the FDA-approved product. These products are not approved for human use, are not held to pharmaceutical manufacturing standards, and may contain the wrong peptide, an inaccurate dose, or bacterial contamination.
Because the drug is a melanocortin receptor agonist, pt-141 peptide side effects from unregulated sources are harder to predict, and a vial labeled "for research use only" offers no guarantee of purity or sterility.
Reports of pt-141 side effects men experience look broadly similar to women's: nausea, flushing, headache, and injection site irritation. Men generally use bremelanotide off-label, since the FDA indication covers premenopausal women only.
Who Should Skip PT-141 and When to Call a Doctor
- Women with uncontrolled high blood pressure
- Women with known cardiovascular disease
- Women who are pregnant or breastfeeding, since no safety data exist
- Anyone using an unregulated "research peptide" version instead of a prescription product
PT-141 is not FDA-approved for postmenopausal women, and it has not been studied in pregnancy or breastfeeding. If you have kidney or liver problems, ask your prescriber whether extra monitoring is needed.
What are the side effects of pt 141 that should prompt a call right away? Severe or persistent vomiting, chest pain, a blood pressure reading that stays high, and new dark patches on the skin all warrant medical attention.
Because PT-141 is a prescription medicine in the U.S., the safest path is to use a licensed prescriber who can review your blood pressure, medications, and cardiovascular history. If side effects are intolerable, alternatives such as flibanserin or counseling are worth discussing.
No medication is risk-free, and results vary widely from person to person. PT-141 side effects in women are usually temporary, but they are real, and the decision to use it belongs with you and your healthcare professional.
Frequently Asked Questions
How common is nausea with PT-141 in women?
Nausea is the most common side effect of bremelanotide, reported by roughly 40% of women in the clinical trials that led to FDA approval. Vomiting occurred in about 5% of participants. Most cases are mild and fade within a few hours, but nausea is the leading reason women stop the medication.
How long do PT-141 side effects last?
Side effects typically begin within an hour of the injection and ease within a few hours. Flushing and nausea tend to fade fastest, while headache or injection site soreness may linger longer. Focal hyperpigmentation, a rare reaction, can persist even after the drug is stopped.
Is PT-141 FDA-approved for women?
Yes, but only for a narrow group. Bremelanotide is approved for premenopausal women with hypoactive sexual desire disorder (HSDD). It is not approved for postmenopausal women, and it is contraindicated in women with uncontrolled high blood pressure or known cardiovascular disease.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.